Breast Conserving Surgery, Radiotherapy, Women With Early Breast Cancer
Conditions
Brief summary
The quality-adjusted life-year (QALY) is the outcome measure of choice in England and Wales for National Institute for Health and Care Excellence (NICE). To be able to conduct a cost utility analysis, QALY data is required. This can either be collected within trial or published data can be used. In the United Kingdom (UK) there is no up to date QALY data for women with early breast cancer treated with surgery followed by radiotherapy. The OSTaRa Study aims to provide up to date QALY data for women in this cohort.
Interventions
OTHEREQ5D questionnaire and a demographic questionnaire
questionnaires
Sponsors
University College, London
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Inclusion criteria
* Female * Over 18 year of age * Has had breast cancer, treated with both breast conserving surgery and radiotherapy. * Is willing to complete an EQ5D and a demographic questionnaire.
Exclusion criteria
* Does not speak sufficiently to complete a study questionnaires. * Has not already been approached to complete an OSTaRa questionnaire.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Questionnaire | 12 months | Each subject will complete an EQ5D questionnaire, to allow Quality of Life to be calculated. The EQ5D uses a Likert scale which assesses five states (mobility, self care, usual care, pain and discomfort and anxiety and depression) at five different levels - none, slight, moderate, severe or unable to perform. Levels are coded 1-5 and a total score is then generated. Results for the demographic measured will be displayed as a percentage value. |
Countries
United Kingdom
Contacts
Primary ContactChris Brew-Graves, MSc
Backup ContactSITU
Outcome results
None listed